Phosphodiesterase-4 as a potential drug target

Author： Zhang Kam YJ   Ibrahim Prabha N   Gillette Sam   Bollag Gideon  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.9, Iss.6, 2005-12, pp. : 1283-1305

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclic AMP-Specific Phosphodiesterase-4 as a Target for the Development of Antidepressant Drugs

By  

Current Pharmaceutical Design, Vol. 15, Iss. 14, 2009-05 ,pp. : 1688-1698

Bentham Science Publishers

Access to resources Recommend Favorite

Subtype Selectivity in Phosphodiesterase 4 (PDE4): A Bottleneck in Rational Drug Design

By  

Current Pharmaceutical Design, Vol. 14, Iss. 36, 2008-12 ,pp. : 3854-3872

Bentham Science Publishers

Access to resources Recommend Favorite

Twist-BRD4 Complex: Potential Drug Target for Basal-like Breast Cancer

By  

Current Pharmaceutical Design, Vol. 21, Iss. 10, 2015-03 ,pp. : 1256-1261

Bentham Science Publishers

Access to resources Recommend Favorite

CDK9 a Potential Target for Drug Development

By  

Medicinal Chemistry, Vol. 4, Iss. 3, 2008-05 ,pp. : 210-218

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiac Calmodulin Kinase: A Potential Target for Drug Design

By  

Current Medicinal Chemistry, Vol. 18, Iss. 24, 2011-08 ,pp. : 3707-3713

Bentham Science Publishers

Access to resources Recommend Favorite